Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.68 |
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | MAPT | P10636 | 4/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.68 |
| ▸ | IDO1 | P14902 | 1/20 | 0.68 |
| ▸ | TDO2 | P48775 | 1/20 | 0.68 |
| ▸ | GFER | P55789 | 1/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 15/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.57 |
| ▸ | CCR6 | P51684 | 1/20 | 0.57 |
| ▸ | RIOK2 | Q9BVS4 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4726180 | 1.00 | L3MBTL1 (0.68) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL20280267 | 0.85 | MAPT (0.63) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL4778752 | 0.85 | MAPT (0.63) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL4778757 | 0.85 | MAPT (0.63) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL29349454 | 0.83 | KDM4E (0.49) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL8661708 | 0.83 | KDM4E (0.49) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL8755605 | 0.83 | KDM4E (0.49) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL1683188 | 0.81 | MAPT (1.00) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL1683189 | 0.81 | MAPT (1.00) | L3MBTL1MEN1MAPTKMT2AMAPK1 | |
| SCHEMBL30875594 | 0.81 | MAPT (1.00) | L3MBTL1MEN1MAPTKMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190091688-A1 | FLUIDIC DEVICES FOR CHROMATOGRAPHIC SEPARATION AND METHODS OF MAKING AND USING THE SAME | OREGON STATE UNIVERSITY (US) | 2019-03-28 | — | — | US | claimed |
| WO-2017210199-A1 | FLUIDIC DEVICES FOR CHROMATOGRAPHIC SEPARATION AND METHODS OF MAKING AND USING THE SAME | OREGON STATE UNIVERSITY (US) | 2017-12-07 | — | — | WO | claimed |
| EP-1980850-A1 | Reagent and Method for Detecting an Adulterant in an Aqueous Sample | Quest Diagnostics Investments Incorporated (US) | 2008-10-15 | — | — | EP | claimed |
| EP-3347001-B1 | AZOPHENOLS AS ERG ONCOGENE INHIBITORS | HENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC (US) | 2023-07-26 | — | — | EP | disclosed |
| US-11389796-B2 | Fluidic devices for chromatographic separation and methods of making and using the same | OREGON STATE UNIVERSITY (US) | 2022-07-19 | — | — | US | disclosed |
| US-20190091688-A1 | FLUIDIC DEVICES FOR CHROMATOGRAPHIC SEPARATION AND METHODS OF MAKING AND USING THE SAME | OREGON STATE UNIVERSITY (US) | 2019-03-28 | — | — | US | disclosed |
| US-10238639-B2 | Azophenols as ERG oncogene inhibitors | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (US) | 2019-03-26 | — | — | US | disclosed |
| US-20180169074-A1 | Azophenols as ERG Oncogene Inhibitors | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (US) | 2018-06-21 | — | — | US | disclosed |
| WO-2017210199-A1 | FLUIDIC DEVICES FOR CHROMATOGRAPHIC SEPARATION AND METHODS OF MAKING AND USING THE SAME | OREGON STATE UNIVERSITY (US) | 2017-12-07 | — | — | WO | disclosed |
| EP-1146062-B1 | Method of producing crosslinkable silyl group-containing polyoxyalkylene polymers | KANEKA CORP (JP) | 2006-12-20 | — | — | EP | disclosed |
| US-6503995-B2 | Hydrosilation | KANEKA CORPORATION (JP) | 2003-01-07 | — | — | US | disclosed |
| US-20020013427-A1 | Method of producing crosslinkable silyl group-containing polyoxyalkylene polymers | KANEKA CORPORATION (JP) | 2002-01-31 | — | — | US | disclosed |
| EP-1146062-A1 | Method of producing crosslinkable silyl group-containing polyoxyalkylene polymers | Kaneka Corporation (JP) | 2001-10-17 | — | — | EP | disclosed |
| US-5790627-A | Method and apparatus for observing a specimen using an X-ray microscope | RESEARCH DEVELOPMENT CORP. (JP) | 1998-08-04 | — | — | US | disclosed |
| EP-0763512-A1 | AIR BAG GAS GENERATING AGENT | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1997-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180169074-A1 | Azophenols as ERG Oncogene Inhibitors | ERG, ESR1, CBX2 | L3MBTL1 2210/4885MEN1 1297/4885MAPT 4076/4885 |
| US-10238639-B2 | Azophenols as ERG oncogene inhibitors | ERG, ESR1, CBX2 | L3MBTL1 2210/4885MEN1 1297/4885MAPT 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.